居里公司近日发布了其创新放射性药物Utreat在一期临床试验中的初步数据,该试验针对高级别胶质瘤患者。初步结果显示,Utreat在试验中表现出积极的疗效和安全性,为后续研究奠定了基础。
居里公司近日发布了其创新放射性药物Utreat在一期临床试验中的初步数据,该试验针对高级别胶质瘤患者。初步结果显示,Utreat在试验中表现出积极的疗效和安全性,为后续研究奠定了基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.